Company

Santarus, Inc.

Santarus develops and commercializes biopharmaceutical therapies for gastrointestinal diseases.

About

Founded in 1996, Santarus developed prescription therapies for gastrointestinal diseases and worked with healthcare providers, hospitals and clinics. The company was based in San Diego, US. In December 2007, it raised USD 54 mn in an IPO on the Nasdaq stock market.

3Funding rounds

11Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in